CF PharmTech Closes US$ 90 Million Financing Round to Accelerate Global Development of Respiratory Drugs

Food and Healthcare Press Releases Thursday January 2, 2020 08:55
SHUZHOU, China--2 Jan--PRNewswire/InfoQuest

CF PharmTech, Inc., a pharmaceutical company with a vision to provide quality and affordable respiratory drug products globally, announced it has raised a $90 million Series E investment led by New Alliance Capital. The investment included participation from new investors CR-CP Life Science Fund, Finnova Capital, GT Capital, Co-stone Asset Management, Xiangcheng Financial Holdings, Everest Venture Capital, and existing investors, such as Oriza Holdings, Longmen Venture Capital, GTJA Investment and CMB International.

The completion of this round of funding reflects the strong support from China's investors to fuel high-caliber pharmaceutical companies that have a strong global competitive edge, and will allow CF PharmTech to bring products in its pipeline to market.

With respect to this round of financing, New Alliance Capital Executive Director Lei Cai explained: "New Alliance Capital prioritizes investment opportunities in the healthcare industries. Respiratory treatments and inhaled medications, in particular, are promising because of the high technological barriers to entry and immense potential for growth. CF PharmTech has worked meticulously to build strong technological platforms that support the development of a comprehensive range of products. The integrity and professionalism of the core team at CF PharmTech impressed us deeply."

CR-CP Life Science Fund Managing Director Da Liu explained: "CF PharmTech is one of China's most innovative and pioneering pharmaceutical companies to focus on respiratory disease treatments. As a pharma company, CF PharmTech fully embodies a commitment to quality and global standards. As one of the few leading private pharmaceutical companies of respiratory drug delivery, CF PharmTech has immense potential for growth."

CEC Capital served as the exclusive financial adviser to CF PharmTech during this Series E round of financing. CEC Capital Partner Irene Hong had this to say: "The close of this financing round will mark a new stage in the product development at CF PharmTech. We greatly admire the persevering spirit of the CF PharmTech team."

About CF PharmTech:

CF PharmTech is a pharmaceutical company dedicated to respiratory health. Since its inception, the company has already established state of the art R&D and manufacturing facilities for inhalation products. Currently, CF PharmTech has a growing pipeline of over 20 products that are headed to China and global markets. Learn more about CF PharmTech, visit

Photo -
Caption: CF PharmTech's manufacturing facility

Latest Press Release

Photo Release: Sri Trang Group donates 2 million gloves to assist efforts in fighting worldwide COVID-19 outbreak.

COVID-19 outbreak has spread tremendously to every continents with the blink of an eye. The outbreak has become a serious treat taken many lives and the number of infected individuals is increasing rapidly. On the 25th February 2020, Mr. Veerasith...

Cybernet Announces World#s First Antimicrobial Touch Glass on a Medical Grade Computer

Cybernet is excited to announce the world's first fully antimicrobial medical computer. Cybernet's medical grade computers have always featured a housing with antimicrobial properties baked directly into the resin, and now can offer a fully antimicrobial...

myONE(TM) set sights to enter condom market in Thailand through the mission to de-stimgatize condom use

myONE(TM), next-generation condoms, was officially launched on Valentine's Day. The brand is affiliated with the ONE(R) Condoms brand that was originally founded in Boston, USA in 2003 and subsequently acquired by Karex, the world's largest condom maker,...

IONpath Launches Research Services Offering Multiplexed Tissue Analysis to Empower Pharmaceutical Discovery and Development Programs

IONpath, Inc., today announces the launch of a dedicated service business providing access to their proprietary MIBIscope(TM) multiplexed imaging platform and its team of experts to support pharmaceutical and biotechnology companies working in...

Vakrangee มุ่งปฏิวัติบริการสุขภาพในชนบทของอินเดีย ผ่านบริการระบบแพทย์ทางไกลโดย vHealth by AETNA

- Vakrangee จับมือ vHealth by Aetna (a CVS Health Company) เพื่อให้บริการสุขภาพดิจิทัลระดับปฐมภูมิแก่ประชาชนในพื้นที่ชนบทของอินเดีย Vakrangee Limited (VL) ประกาศความร่วมมือเป็นพันธมิตรกับ vHealth by Aetna ในเครือ Aetna Inc, a CVS Health Company...

Related Topics